Thus, diminished expression of these cell membrane receptors may be the key feature of the hemodialysis-associated decline of CD4+ T cell function, which can serve as clinical indicators for monitoring the acquired immunity system in HD patients. The gene discussed is CD4; the disease is Huntington disease.